Cargando…
Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
Pancreatic cancer (PC) is among the deadliest cancers, with a median survival of six months. It is generally believed that infiltrating PC arises through the progression of early grade pancreatic intraepithelial lesions (PanINs). In one model of the disease, the K-ras mutation is an early molecular...
Autores principales: | Mehta, Kapil, Han, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756395/ https://www.ncbi.nlm.nih.gov/pubmed/24212645 http://dx.doi.org/10.3390/cancers3010897 |
Ejemplares similares
-
Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer
por: Agnihotri, Navneet, et al.
Publicado: (2013) -
Discovery and
Characterization of PROTACs Targeting
Tissue Transglutaminase (TG2)
por: Valdivia, Andres, et al.
Publicado: (2023) -
The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression
por: Tabolacci, Claudio, et al.
Publicado: (2019) -
Tissue transglutaminase in the pathogenesis of heart failure
por: Shinde, Arti V., et al.
Publicado: (2017) -
Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion
por: Mangala, Lingegowda S, et al.
Publicado: (2005)